TP53 and breast cancer: (2021), miR-200c was found to affect p53 regulation: with p53 deficiency, its expression is reduced and the epithelial–mesenchymal transition (EMT) and stem cell-like phenotype is induced, which will ultimately lead to the development of breast cancer.